Stock Events

Stock Events

Crinetics Pharmaceuticals (CRNX) Q2 2025 Earnings

8MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-1.04

-0.98

-0.92

-0.86

Details

Expected EPS

-0.940833

Actual EPS

-1.04

Surprise EPS

-0.1

Surprise Percent

+10.54%

Description

Crinetics Pharmaceuticals (CRNX) has reported earnings of -1.04 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.